Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 4, 2023. (Total: 217641Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 10 (of 10 Records)

Query Trace: Sarcoma and EML4[original query]
CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes.
Human pathology 2013 Jul 44 (7): 1382-90.
Koga Takaomi, Takeshita Masafumi, Ijichi Kayo, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients.
OncoTargets and therapy 2014 7 513-24.
Li Hang, Hu Haichuan, Wang Rui, Pan Yunjian, Wang Lei, Li Yuan, Zhang Yang, Ye Ting, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu
Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?
Neuro-oncology 2015 Jul 17 (7): 1022-8.
Wang Tony J C, Saad Shumaila, Qureshi Yasir H, Jani Ashish, Nanda Tavish, Yaeh Andrew M, Rozenblat Tzlil, Sisti Michael B, Bruce Jeffrey N, McKhann Guy M, Lesser Jeraldine, Halmos Balazs, Stoopler Mark B, Lassman Andrew B, Cheng Simon K, Isaacson Steven
Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.
Clinical lung cancer 2015 Dec .
Ulivi Paola, Chiadini Elisa, Dazzi Claudio, Dubini Alessandra, Costantini Matteo, Medri Laura, Puccetti Maurizio, Capelli Laura, Calistri Daniele, Verlicchi Alberto, Gamboni Alessandro, Papi Maximilian, Mariotti Marita, De Luigi Nicoletta, Scarpi Emanuela, Bravaccini Sara, Turolla Gian Michele, Amadori Dino, Crinò Lucio, Delmonte Ange
Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Apr .
Chen Yen-Fu, Hsieh Min-Shu, Wu Shang-Gin, Chang Yih-Leong, Yu Chong-Jen, Yang James Chih-Hsin, Yang Pan-Chyr, Shih Jin-Yu
Genetic alterations in lung adenocarcinoma with a micropapillary component.
Molecular and clinical oncology 2016 Feb 4 (2): 195-200.
Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi
The expression of SALL4 is significantly associated with EGFR, but not KRAS or EML4-ALK mutations in lung cancer.
Journal of thoracic disease 2016 Oct 8 (10): 2682-2688.
Jia Xiangbo, Qian Rulin, Zhang Binbin, Zhao So
[Gene Expression and Clinical Characteristics of Molecular Targeted Therapy ?in Non-small Cell Lung Cancer Patients in Shandong].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2017 Jan 20 (1): 14-20.
Qiao Xiuli, Ai Dan, Liang Honglu, Mu Dianbin, Guo Qis
Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations.
Oncotarget 2018 Apr 9 (28): 19891-19899.
Somaiah Neeta, Beird Hannah C, Barbo Andrea, Song Juhee, Mills Shaw Kenna R, Wang Wei-Lien, Eterovic Karina, Chen Ken, Lazar Alexander, Conley Anthony P, Ravi Vinod, Hwu Patrick, Futreal Andrew, Simon George, Meric-Bernstam Funda, Hong Dav
Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib.
Translational lung cancer research 2021 4 10 (3): 1525-1535.
Li Jingjing, Zhang Bin, Zhang Yu, Xu Feng, Zhang Zhenfa, Shao Lin, Yan Chunhe, Ulivi Paola, Denis Marc G, Christopoulos Petros, Thomas de Montpréville Vincent, Bernicker Eric H, van der Wekken Anthonie J, Wang Changli, Yue Dongshe
TOP